Results 71 to 80 of about 2,312,469 (251)

Experiencias terapéuticas en la uveítis intermedia Therapeutical experiences in intermediate uveitis

Revista Cubana de Oftalmología, 1999
Se realiza el estudio de 41 pacientes portadores de uveítis intermedia donde se definen aspectos de su ubicación anatómica, cuadro clínico y complicaciones como las opacidades vítreas, cataratas, desprendimiento de retina y otras.
Sandra Borges Pérez, Caridad Monteagudo Morejón, Edith Ballate Nodales, Maricel Moxam Cleghon   +3 more
doaj  

Prevalence, clinical characteristics, and independent predictors of uveitic macular edema in an Asian population: a retrospective cohort study

BMC Ophthalmology
Background To determine the prevalence, clinical characteristics, and independent predictors of uveitic macular edema (UME) in patients with intermediate, posterior and panuveitis.
Usanee Tungsattayathitthan, Sukanda Jenjanya, Pitipol Choopong, Wilawan Sanphan, Nattaporn Tesavibul, Sutasinee Boonsopon   +5 more
doaj   +1 more source

Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period

Diagnostics
Objectives: The aim of this study was to establish the etiology of uveitis and to examine its relationship with anatomical localization, age, and gender.
Vesela Todorova Mitkova-Hristova, Marin Anguelov Atanassov, Yordanka Mincheva Basheva-Kraeva, Velichka Zaharieva Popova, Krasimir Iliev Kraev, Steffanie Hristova Hristova   +5 more
doaj   +1 more source

An Aggregation‐Induced Polymerization Poly(Disulfide)‐Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS‐STING Pathway

Advanced Science, EarlyView.
A cationic poly(disulfide)‐drug nanoplatform (LA/DexP) was developed to treat experimental autoimmune uveitis (EAU). With potent blood‐retinal barrier penetrability, LA/DexP releases DSP in response to high ROS and scavenges cfDNA to inhibit the cGAS‐STING signaling pathway.
Yuelan Wu, Wenbo Geng, Qinjin Dai, Wanyun Zhang, Yuxian Lai, Pei Zhang, Chunjiang Zhou, Yinuo Wang, Qingfeng Cao, Xiang Luo, Yujie Lai, Changwei Huang, Peizeng Yang   +12 more
wiley   +1 more source

Uveítis intermedia: Experiencias terapéuticas Intermediate uveitis: Therapeutic experiences

Revista Cubana de Oftalmología, 2001
Se realizó un estudio descriptivo prospectivo a 50 ojos (41 pacientes) con el diagnóstico de uveítis intermedia durante un período de 3 años. Esta patología fue más frecuente en la mujer (58 %), en edades jóvenes (25 a 45 años) y en plena actividad ...
Sandra M. Borges Pérez, Maricel Moxam Cleghorn, Katia Áreas Salas, Edith María Ballate Nodales   +3 more
doaj  

Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia

Journal of Ophthalmic Inflammation and Infection, 2022
Introduction Uveitis is one of the common causes of visual impairment in Malaysia. It remains a challenging entity to diagnose and manage due to variation in its clinical presentation.
Rajasudha Sawri Rajan, Shelina Oli Mohamed, Mohamad Aziz Salowi, Malaysian Uveitis Study Group, Ministry of Health Malaysia   +4 more
doaj   +1 more source

A Rare De Novo Missense Mutation in IFT122 Confers a Genetic Susceptibility Factor of Idiopathic Pediatric Uveitis Via Trio‐based Whole‐Exome Sequencing

Advanced Science, EarlyView.
A rare de novo IFT122‐A773E variant is identified in idiopathic pediatric uveitis and shown to exacerbate retinal inflammation and barrier dysfunction. Mechanistically, the variant enhances IFT43 interaction, elevates calcium signaling, and activates the MEK/ERK/FRA1 axis, revealing a previously unrecognized cilia‐associated pathway that may increase ...
Qian Zhou, Jiaxing Huang, Yilin Wang, Xingran Li, Xianyang Liu, Lingyu Dai, Hongshun Li, Qingfeng Wang, Jiangyi Liu, Guannan Su, Wanyun Zhang, Yang Deng, Qingfeng Cao, Yujie Lai, Xiang Luo, Changwei Huang, Ling Chen, Shengping Hou, Peizeng Yang   +18 more
wiley   +1 more source

Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma

Advanced Science, EarlyView.
This review evaluates nanoparticle‐based phototherapies for uveal melanoma, highlighting emerging strategies to enhance tumor targeting, light delivery, and treatment precision. Preclinical data indicate improved efficacy and reduced toxicity, supporting their potential to enhance localized treatment and future translational advances. (Generated by the
Emilie Lambert, Christophe Nguyen, Sean Edward Dunn, Magali Gary‐Bobo, Jérôme Lacombe, Justin Moser, Frédéric Zenhausern, Jean‐Olivier Durand, Frédérique Cunin   +8 more
wiley   +1 more source

A pediatric case with parvovirus B19-associated uveitis without autoantibody formation [PDF]

, 2018
2018-11Acute parvovirus B19 (B19) infection is often accompanied by autoantibody formation, including antinuclear antibodies and rheumatoid factor, and the symptoms of the infection are similar to those of several autoimmune diseases.
Ito, Takuma, Mizuki, Kazuyoshi, Ishibashi, Shingo, Kusuhara, Koichi, Hoshina, Takayuki, Fukuda, Tomofumi   +5 more
core   +1 more source

Upadacitinib Restrains the Pathogenic Fitness of CD4+ T Cells and Aberrant B Cell Programming in Optic Neuritis

Advanced Science, EarlyView.
Single‐cell profiling and functional perturbation reveal coordinated JAK1‐pSTAT3 downstream programs in optic neuritis, including MCL1‐dependent fitness of pathogenic CD4+ Tem cells and glycolysis‐linked, cholesterol‐sensitive B‐cell responses associated with RORA. Upadacitinib disrupts this reciprocal T‐B‐cell circuit and alleviates neuroinflammation,
Gengchen Jiang, Qi Jiang, Lian Han, Yue Peng, Xingyu Liu, Tong Yang, Hao Huang, Jiaying Liu, Yuan Gao, Hui Yang, Wenjun Zou, Zhaohuai Li, Wenru Su   +12 more
wiley   +1 more source